Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Imaging catheters recalled due to injury risk | A new use for metformin? | Open vs. endovascular AAA repair
Friday, May 27, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

There have been five reported incidents so far, including one patient injury.

READ MORE >
Dragonfly OpStar Imaging Catheter FDA recall May 2022
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

Share on Twitter Share on Facebook Share on Linkedin
Dragonfly OpStar Imaging Catheter FDA recall May 2022
There have been five reported incidents so far, including one patient injury.
READ MORE >

A new use for metformin? Popular type 2 diabetes medication may also improve cancer and infection therapies

Metformin appears to improve the impact of chemodynamic therapy, according to a new analysis in Nano Research. 

READ MORE >
metformin chemodynamic therapy type 2 diabetes Nano Research
Share on Twitter Share on Facebook Share on Linkedin

A new use for metformin? Popular type 2 diabetes medication may also improve cancer and infection therapies

Share on Twitter Share on Facebook Share on Linkedin
metformin chemodynamic therapy type 2 diabetes Nano Research
Metformin appears to improve the impact of chemodynamic therapy, according to a new analysis in Nano Research. 
READ MORE >

Open AAA repair linked to better long-term outcomes than EVAR

However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  

READ MORE >
Abdominal aortic aneurysm (AAA)
Share on Twitter Share on Facebook Share on Linkedin

Open AAA repair linked to better long-term outcomes than EVAR

Share on Twitter Share on Facebook Share on Linkedin
Abdominal aortic aneurysm (AAA)
However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  
READ MORE >

Featured Articles

VIDEO: What interventional cardiologists need to perform pulmonary embolism thrombectomy

There is a national trend where cardiology is increasingly being called in to help with PE response teams (PERT) at hospitals. Terry Bowers from Beaumont explains what skills interventional cardiologists need for PE procedures.

READ MORE >
Terry Bowers, MD, director of vascular medicine at Beaumont Hospital, Royal Oak, Michigan, and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the skillset needed for pulmonary embolism (PE) thrombectomy procedures. #PERT #PE
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: What interventional cardiologists need to perform pulmonary embolism thrombectomy

Share on Twitter Share on Facebook Share on Linkedin
Terry Bowers, MD, director of vascular medicine at Beaumont Hospital, Royal Oak, Michigan, and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the skillset needed for pulmonary embolism (PE) thrombectomy procedures. #PERT #PE
There is a national trend where cardiology is increasingly being called in to help with PE response teams (PERT) at hospitals. Terry Bowers from Beaumont explains what skills interventional cardiologists need for PE procedures.
READ MORE >

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 

READ MORE >
Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.
Share on Twitter Share on Facebook Share on Linkedin

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

Share on Twitter Share on Facebook Share on Linkedin
Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.
The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 
READ MORE >

LVAD patients spend nearly 1 in 4 days seeking care — is there a more effective way?

The study's authors noted that LVADs consistently lead to strong outcomes, but improvements are still needed to reduce the burden on patients. 

READ MORE >
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
Share on Twitter Share on Facebook Share on Linkedin

LVAD patients spend nearly 1 in 4 days seeking care — is there a more effective way?

Share on Twitter Share on Facebook Share on Linkedin
Treating elderly atrial fibrillation (AFib) patients—even those who are traditionally ineligible for direct oral anticoagulants (DOACs)—with a very low dose of edoxaban is associated with improved outcomes, according to new research published in JAMA Network Open.
The study's authors noted that LVADs consistently lead to strong outcomes, but improvements are still needed to reduce the burden on patients. 
READ MORE >

In Case You Missed It

Arterial stiffness may predict type 2 diabetes risk better than high blood pressure

Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Arterial stiffness may predict type 2 diabetes risk better than high blood pressure

Share on Twitter Share on Facebook Share on Linkedin
Researchers tracked data from more than 11,000 adult patients, sharing their findings in Hypertension.
READ MORE >

In Other News

VIDEO: Why the ASNC did not support the 2021 Chest Pain Evaluation Guidelines

Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology, said the group had issues with the document's elevation of cardiac CT and FFR-CT. 

READ MORE >
The American Society fo Nuclear Cardiology (ASNC) did not support the 2021 Chest Pain Guidelines because of the high support for cardiac CT and FFR-CT.
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Why the ASNC did not support the 2021 Chest Pain Evaluation Guidelines

Share on Twitter Share on Facebook Share on Linkedin
The American Society fo Nuclear Cardiology (ASNC) did not support the 2021 Chest Pain Guidelines because of the high support for cardiac CT and FFR-CT.
Randall Thompson, MD, immediate past president of the American Society of Nuclear Cardiology, said the group had issues with the document's elevation of cardiac CT and FFR-CT. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme